GlassScriptPhysician profile
Amy S Mahar
NPI 1750352480
$1,464.42
in general payments reported to CMS, 2019-2025
15 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.56 · 2022: $245 · 2023: $249 · 2024: $533 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.78 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $410.49 | 2021-2024 | Ozempic, Rybelsus |
| Abbott Laboratories | $297.03 | 2022-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $98.51 | 2021-2024 | Dexcom G6 Transmitter |
| Lilly USA, LLC | $95.79 | 2021-2025 | Mounjaro, Zepbound, Lyumjev |
| Astrazeneca Pharmaceuticals LP | $87.15 | 2023-2024 | Farxiga |
| Tandem Diabetes Care, INC. | $81.40 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $81.34 | 2023-2025 | Minimed 780g |
| Corcept Therapeutics | $70.47 | 2023-2025 | Korlym |
| Ascendis Pharma Endocrinology INC | $49.94 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $48.31 | 2022-2024 | Gvoke Hypopen |
| Mannkind Corporation | $42.50 | 2025 | |
| Nevro Corp. | $39.08 | 2024 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.19 | 2025 | Jardiance |
| Amgen INC. | $17.00 | 2025 | Evenity |
| Beta Bionics, INC. | $15.22 | 2024 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Mahar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.